×
GreekEnglish

×
Sunday
24
Nov 2024
weather symbol
Athens 8°C

> European Medicines Agency (EMA)

> European Medicines Agency (EMA)

EMA approves conditional use of Pfizer Covid Paxlovid pill

Merck's pill is also under review by the EMA

EMA says there is no evidence for 4th Covid booster for general population

EMA also said continued vaccine boosters could reduce the level of antibodies

Coronavirus – EMA approves use of Novavax vaccine

The EMA granted conditional marketing authorization

EMA approves use of Pfizer vaccine for children aged 5 to 11

The doses will be lower than for people over 12

European Medicines Agency (EMA) approves two monoclonal antibody drugs for Covid-19

EMA is currently evaluating six other drugs

Nordic countries to hold off resumption of AstraZeneca vaccination until next week

They want to further examine its negative side effects

European Medicines Agency says AstraZeneca is safe, but urged citizens to report any side-effects

EMA added that it can not rule out a definite link between these cases (blood clot) and the vaccine

National Vaccination Committee: Vaccination with AstraZeneca continues

There is no reason for the AstraZeneca vaccinations to be halted

Coronavirus: Europe approves Johnson & Johnson vaccine

It can be stored in normal refrigerators for up to three months and requires a single dose

Meeting to approve Pfizer vaccine on 21 December – European Medicines Agency speeds up approval process

It was originally scheduled for December 29